Institutional investors purchased a net $1.5 million shares of OHRP during the quarter ended December 2017, and now own 15.53% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 503.4 Thousand shares of OHR Pharmaceutical Inc
AIGH CAPITAL MANAGEMENT LLC Bought 324.7 Thousand shares of OHR Pharmaceutical Inc